a2z Radiology AI Expands Acute Care Suite with Third FDA-Cleared Device

New FDA clearance brings a2z’s abdomen-pelvis CT triage portfolio to 26 findings across three devices.

a2z logo
a2z logo

BOSTON–(BUSINESS WIRE)–a2z Radiology AI Inc. today announced FDA clearance of a2z-Omni-Triage, its third FDA-cleared device for triage and notification on abdomen-pelvis CT.

a2z-Omni-Triage flags suspected cases of nine findings: moderate or large layering pleural effusion, pneumothorax, complex pleural collection, bowel perforation, moderate or severe hydronephrosis, large aortic aneurysm (5 cm or larger), non-sacral pelvic fracture, sacral or coccygeal fracture and soft tissue abscess. It joins a2z-Unified-Triage, cleared for seven findings, and a2z-Abdo-Triage, cleared for ten. Each device’s findings were cleared with their own definitions and performance testing.

“A CT scan ordered for abdominal pain shows far more than the abdomen, from the base of the lungs to the bones of the pelvis,” said Samir Rajpurkar, co-founder and CEO of a2z Radiology AI. “a2z-Omni-Triage can flag nine findings across that range for the care team.”

“On a busy shift with a long worklist, even a CT ordered as routine can turn out to need urgent attention,” said Michael Moritz, MD, CIIP, Chief Medical Information Officer of a2z Radiology AI. “a2z-Omni-Triage helps bring those studies with suspected findings forward for review.”

“A scan isn’t read one finding at a time, and the software that supports clinicians shouldn’t stop at one either,” said Pranav Rajpurkar, PhD, co-founder of a2z Radiology AI and Associate Professor of Biomedical Informatics at Harvard Medical School.

a2z-Omni-Triage analyzes abdominopelvic CT images acquired with or without intravenous contrast in adults aged 22 and older. It works in parallel with standard-of-care image interpretation, and notified clinicians remain responsible for viewing the full images. Findings involving the chest apply only when that anatomy is included in the images analyzed.

About a2z Radiology AI

a2z Radiology AI builds AI to support care teams in acute care imaging, starting with abdomen-pelvis CT. The name a2z reflects its founding ambition to support comprehensive medical image interpretation, from A to Z.

The company was co-founded by Pranav Rajpurkar, an Associate Professor of Biomedical Informatics at Harvard Medical School, and Samir Rajpurkar, a technology entrepreneur. a2z is backed by Khosla Ventures and SeaX Ventures.

For more information, visit a2zradiology.ai.

Contacts

Media contact: a2z Radiology AI, [email protected]

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Stay up-to-date with the latest Newsletters, free of charge.